Nazario Cassaro

ORCID: 0000-0003-1955-4620 · 2 papers in corpus
2022
BMC cancer ·doi:10.1186/s12885-022-10179-1

BackgroundAlthough there is broad consensus that only a subset of CIN3 will progress to cancer, there is currently no surefire way to predict which CIN3 will regress. Understanding the natural history of CIN3 is important, and finding marke…

article 2000
Minerva ginecologica

Tamoxifen is a synthetic non-steroid anti-estrogen that has been used effectively for several years in the adjuvant treatment of breast cancer. Although its therapeutic effect is due to its anti-estrogenic properties, the drug also shows mo…